Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 509.00
Bid: 506.00
Ask: 512.00
Change: 11.00 (2.20%)
Spread: 6.00 (1.186%)
Open: 503.00
High: 512.00
Low: 508.00
Prev. Close: 501.00
OCI Live PriceLast checked at -
Oakley Capital Investments is an Investment Trust

To achieve capital appreciation through investments in a diversified portfolio of private mid-market businesses primarily in Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update for the Six Months Ended 30 June 21

28 Jul 2021 07:00

RNS Number : 6711G
Oakley Capital Investments Limited
28 July 2021
 

28 July 2021

Oakley Capital Investments Limited

 

Trading Update for the Six Months ended 30 June 2021

 

 Portfolio strength drives 11% NAV uplift

 

Oakley Capital Investments Limited1 ("OCI" or the "Company"), a listed investment company providing investors access to the Oakley Funds2, today announces a trading update for the six months ended 30 June 2021.

 

Highlights for the period

Net Asset Value ("NAV") per share of 445 pence

Total NAV return per share of 11% since 31 December 2020

The Company invested £95 million and its share of proceeds was £51 million

Cash of £172 million at 30 June 2021

Outstanding Oakley Fund commitments of £438 million

 

NAV growth

The Company's unaudited NAV at 30 June 2021 was £804 million, which represents a NAV per share of 445 pence, based on portfolio company valuations at the half-year. The total NAV per share return including dividends is 11% (+45 pence) since 31 December 2020 and 26% (+94 pence) since 30 June 2020.

Portfolio company performance

During the period, the Oakley Funds sustained their pattern of solid performance and EBITDA growth. While the impact of the COVID pandemic continues, the portfolio has continued to benefit from an investment focus on technology-enabled businesses. Of the current portfolio, 14 companies accounting for 52% of NAV* grew their revenues at or above expectations in the period. Four companies accounting for 14% of NAV* have seen a modest COVID impact on financial performance. Meanwhile, three companies accounting for 29% of NAV* continue to be significantly impacted by ongoing, Europe-wide COVID-related restrictions.

Percentages shown are OCI's look-through exposure to the portfolio companies via the Funds and direct investments.

Proceeds

The Company's share of proceeds from divestments, refinancings and repayment of loans amounted to £51 million, consisting of the refinancing of IU Group, the repayment of the Daisy loan and the exit of Fund II's stake in the Digital Wholesale Solutions division of portfolio company Daisy Group.

Investments

In the trading period, the Investment Adviser3 continued to originate proprietary opportunities for the Oakley Funds within its focus sectors, namely Technology, Consumer and Education. During the period, OCI made a total look-through investment of £95 million which, aside from some minor follow-on investments, was attributable to the acquisition of four new platform investments: idealista (Fund IV), Dexters (Fund IV), ICP Education (Fund IV) and ECOMMERCE ONE (Origin Fund).

Cash & commitments

Balance sheet - OCI has no leverage and had cash on the balance sheet of £172 million at 30 June 2021, comprising 21% of NAV

Recent commitments - OCI's total commitment to the Oakley Capital Origin Fund, which closed in January 2021, was €129 (£111) million

Total outstanding commitments - outstanding Oakley Fund commitments are £438 million

 

Post-balance sheet events

Exit and follow-on investment - Fund III sold its stake in ACE Education ("ACE") to Groupe Amaury with its share of proceeds being £16 million. As part of the transaction, the Origin Fund invested in ACE alongside Groupe Amaury. OCI's indirect contribution via the Origin Fund was £10 million

 

The Company expects to report its unaudited interim results for 2021 on Thursday 9 September 2021.

A live presentation of the trading update, delivered by Oakley Capital Partner Steven Tredget, will be broadcast online on Thursday 29 July 2021 at 12:00pm BST.

 

The interactive event will be available free via the Investor Meet Company platform. Register to join the event at: https://www.investormeetcompany.com/oakley-capital-investments-limited/register-investor

 

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

 

Greenbrook Communications Limited

+44 20 7952 2000

Alex Jones / Michael Russell

 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Chris Clarke / Darren Vickers / Owen Matthews

 

Notes:

This announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019

LEI Number: 213800KW6MZUK12CQ815

About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds2.

An introduction to OCI video is available at https://oakleycapitalinvestments.com/videos/

2 The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV and Oakley Capital Origin Fund are unlisted lower-mid to mid-market private equity funds with the aim of providing investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

3 The Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAEXXASDFEAA
Date   Source Headline
28th Jun 20247:00 amRNSOakley agrees sale of its investment in idealista
11th Jun 20247:00 amRNSOakley to invest in cybersecurity firm I-TRACING
7th Jun 20247:00 amRNSDirector Dealing
3rd Jun 20243:43 pmRNSResult of AGM
28th May 20247:00 amRNSOakley Capital invests in ProductLife Group
14th May 20247:00 amRNSOakley Capital invests in vitroconnect
8th May 20247:00 amRNSNotice of Annual General Meeting
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.